It is the cache of ${baseHref}. It is a snapshot of the page. The current page could have changed in the meantime.
Tip: To quickly find your search term on this page, press Ctrl+F or ⌘-F (Mac) and use the find bar.

Update on the diagnosis and management of acute kidney injury
skip to content
Dovepress - Open Access to Scientific and Medical Research
View our mobile site

14804

Update on the diagnosis and management of acute kidney injury



Review

(11336) Total Article Views


Authors: Ali Akcay, Kultigin Turkmen, DongWon Lee, et al

Published Date September 2010 Volume 2010:3 Pages 129 - 140
DOI: http://dx.doi.org/10.2147/IJNRD.S8641

Ali Akcay, Kultigin Turkmen, DongWon Lee, Charles L Edelstein
Division of Renal Diseases and Hypertension, University of Colorado and the Health Sciences Center, Aurora, Colorado, USA

Abstract: Acute kidney injury (AKI) is an independent risk factor for morbidity and mortality. This review provides essential information for the diagnosis and management of AKI. Blood urea nitrogen and serum creatinine are used for the diagnosis of AKI. The review also focuses on recent studies on the diagnosis of AKI using the RIFLE (R-renal risk, I-injury, F-failure, L-loss of kidney function, E-end stage kidney disease) and Acute Kidney Injury Network criteria, and serum and urine AKI biomarkers. Dialysis is the only Food and Drug Administration-approved therapy for AKI. Recent studies on the dose of dialysis in AKI are reviewed.

Keywords: acute kidney injury, biomarkers, interleukin-18


Post to:
Cannotea Citeulike Del.icio.us Facebook LinkedIn Twitter


Readers of this article also read: